Published on Pfizer: the world's largest research-based pharmaceutical company (http://www.pfizer.com)

Home > Partnering > Partnering Highlights > Partnering Highlights

Partnering Highlights

Partnering Highlights

When we think partnerships, we think diverse, bold, and inspired. It's in those partnerships where we can find an innovative medicine that saves a life. Or the licensing deal that broadens access to a critical drug. Or the technology collaboration that brings an experimental medicine to clinical trials faster. Or, even a business process that improves the way we help our customers.

Our partnerships, while individualized in scope and breadth, all offer the possibility of a healthier world. Read about some of our partnerships

Recent Partnerships

Pages

  • previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • next
January 5, 2012 Catalyst Biosciences, Inc. announced that Pfizer Inc. has initiated a Phase 1 clinical trial for PF-05280602, an investigational proprietary, engineered variant of recombinant human Factor VIIa developed by Catalyst Biosciences.
December 25, 2011 CollPlant Holdings Ltd. announced that CollPlant Ltd has signed a development agreement with Pfizer Inc., for the co-development of a product targeting the orthopedic market.
December 24, 2011 Karo Bio AB announced that it has entered into a research collaboration agreement with Pfizer to discover and develop novel small molecule RORgamma modulators for the treatment of autoimmune diseases.
December 20, 2011 Antares announced a licensing deal with Pfizer Consumer Healthcare.
December 13, 2011 Progress of GlycoMimetics' Novel Compounds Highlighted
December 1, 2011 Pfizer Completes Acquisition of Ferrosan Consumer Health's Business
Printable Version
 
 

Submit Your Opportunity

callout-placeholder

Send us your innovative ideas today.

  • Get started now

Source URL: http://www.pfizer.com/partnering/partnership_highlights/index?page=4